Anticholinergics are a class of drugs that work by inhibiting the activity of the neurotransmitter acetylcholine (ACh), which plays a key role in the parasympathetic nervous system. The term "anticholinergic" can be broken down into "anti-" meaning "against," and "cholinergic," referring to the action of acetylcholine. Acetylcholine is essential for many involuntary bodily functions, such as contraction of smooth muscles, dilation of blood vessels, and regulation of secretions. Anticholinergics block acetylcholine's effects by binding to and inhibiting its receptors. These receptors include muscarinic receptors, which are found in the central and peripheral nervous systems and regulate organ functions, and nicotinic receptors, which exist in the neuromuscular junction and the central nervous system.
Anticholinergic drugs are divided into two main categories: antimuscarinics, which target muscarinic receptors, and anti nicotinic, which inhibit nicotinic receptors. Antimuscarinics, such as atropine and scopolamine, are primarily used to treat conditions like bradycardia (a slow heart rate), overactive bladder, and irritable bowel syndrome. On the other hand, anti nicotinic, such as ipratropium and atracurium, are used in anesthesia for muscle relaxation and are employed in treating respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). These drugs serve a wide range of therapeutic purposes but also carry potential side effects, especially when they cross the blood-brain barrier, potentially causing confusion or disorientation.
